Acrivon Therapeutics, Inc. Common Stock (ACRV) vs Cardiff Oncology, Inc. (CRDF)

A side-by-side comparison of Acrivon Therapeutics, Inc. Common Stock and Cardiff Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Acrivon Therapeutics, Inc. Common Stock logo
ACRV
Acrivon Therapeutics, Inc. Common Stock
$85M
$1.99HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Cardiff Oncology, Inc. logo
CRDF
Cardiff Oncology, Inc.
$87M
$1.14HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT

Total return — ACRV vs CRDF

growth of $100 · dividends reinvested · last 4y
ACRV -88.1% (-41.3%/yr)CRDF -18.0% (-4.8%/yr)CRDF compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002023202420252026$12$82
ACRV CRDF

ACRV vs CRDF: by the numbers

  • •CRDF is the larger company ($87M vs $85M market cap).
  • •Both run net losses; ACRV's is the smaller (0.00% vs -7884.06% net margin).

Metrics side by side

Valuation

MetricACRVCRDF
P/S ratioN/A172.20
P/B ratio0.983.30

Profitability

MetricACRVCRDF
Gross margin0.00%100.00%
Operating margin0.00%-8256.32%
Net margin0.00%-7884.06%
ROE-85.65%-150.95%
ROIC-88.28%-159.30%

Growth (annualized)

MetricACRVCRDF
Revenue CAGR (5Y)N/A5.15%
Total return CAGR (5Y)N/A-30.36%

Go deeper

Full ACRV analysisFull CRDF analysisInteractive comparison tool

Dig into the metrics

Acrivon Therapeutics, Inc. Common Stock ROECardiff Oncology ROEAcrivon Therapeutics, Inc. Common Stock operating marginCardiff Oncology operating marginAcrivon Therapeutics, Inc. Common Stock revenue growthCardiff Oncology revenue growthAcrivon Therapeutics, Inc. Common Stock free cash flowCardiff Oncology free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.